Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19157429 | 0.86 | — | — | |
| SCHEMBL13824330 | 0.86 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL14619859 | 0.82 | CYP4F2 (0.36) | ALDH1A1 | |
| SCHEMBL13467183 | 0.81 | THRB (0.31) | — | |
| SCHEMBL4572351 | 0.81 | ALDH1A1 (0.30) | ALDH1A1 | |
| SCHEMBL13069960 | 0.81 | — | — | |
| SCHEMBL23057041 | 0.80 | THRB (0.30) | — | |
| SCHEMBL14317417 | 0.80 | ALDH1A1 (0.30) | ALDH1A1 | |
| SCHEMBL19157591 | 0.80 | — | — | |
| SCHEMBL20218848 | 0.80 | THRB (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230365484-A1 | PROCESS OF PREPARING FLUOROETHER COMPOUNDS WITH UNSATURATED END GROUPS | MERCK PATENT GMBH (DE) | 2023-11-16 | — | — | US | disclosed |
| US-11667742-B2 | Compositions with high refractive index and Abbe number | Johnson & Johnson Surgical Vision, Inc. (US) | 2023-06-06 | — | — | US | disclosed |
| EP-3728337-B1 | HYDROGENATION OF NITRILE BUTADIENE RUBBER LATEX | ARLANXEO DEUTSCHLAND GMBH (DE) | 2022-02-09 | — | — | EP | disclosed |
| US-20200347167-A1 | COMPOSITIONS WITH HIGH REFRACTIVE INDEX AND ABBE NUMBER | Johnson & Johnson Surgical Vision, Inc. | 2020-11-05 | — | — | US | disclosed |
| EP-3330294-B1 | POWER TRANSMISSION BELT | DAYCO EUROPE SRL (IT) | 2020-08-26 | — | — | EP | disclosed |
| WO-2018104860-A1 | POWER TRANSMISSION BELT | DAYCO EUROPE S.R.L. (IT) | 2018-06-14 | — | — | WO | disclosed |
| EP-3330294-A1 | POWER TRANSMISSION BELT | Dayco Europe S.R.L. (IT) | 2018-06-06 | — | — | EP | disclosed |
| US-20170133712-A1 | ALL SOLID-STATE SECONDARY BATTERY, SOLID ELECTROLYTE COMPOSITION, ELECTRODE SHEET FOR BATTERY USING SAME, METHOD FOR MANUFACTURING ELECTRODE SHEET FOR BATTERY, AND METHOD FOR MANUFACTURING ALL SOLID-STATE SECONDARY BATTERY | FUJIFILM CORPORATION (JP) | 2017-05-11 | — | — | US | disclosed |
| US-20170035895-A1 | DEHYDRATED HYDROGEL INCLUSION COMPLEX | INDIVIOR UK LIMITED (F/K/A RB PHARMACEUTICALS LIMITED) (GB) | 2017-02-09 | — | — | US | disclosed |
| US-20120122694-A1 | VERBESSERTE MICROKAPSELN UND IHRE HERSTELLUNG IMPROVED MICROCAPSULES, AND THEIR PRODUCTION THEREOF | Follmann & Co. Gesellschaft fur Chemie-Werkstoffe und Verfahrenstechnik mbH & Co. KG (DE) | 2012-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230365484-A1 | PROCESS OF PREPARING FLUOROETHER COMPOUNDS WITH UNSATURATED END GROUPS | ELOVL3, FDPS, FASN | ALDH1A1 1660/4885 |
| US-20120122694-A1 | VERBESSERTE MICROKAPSELN UND IHRE HERSTELLUNG IMPROVED MICROCAPSULES, AND THEIR PRODUCTION THEREOF | VIM, ADH5, DCXR | ALDH1A1 367/4885 |
| US-20170035895-A1 | DEHYDRATED HYDROGEL INCLUSION COMPLEX | IGFBP1, IGFBP6, IGFBP5 | ALDH1A1 1384/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.